FAKTOR-OPTIONSSCHEIN - SMITH & NEPHEW | Market Closed - Börse Stuttgart 06:00:07 2024-05-24 EDT | ||
| 8.64 EUR | -16.20% |
|
| Current month | -15.95% | ||
| 1 month | -22.44% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
SMITH & NEPHEW PLC
Latest news about SMITH & NEPHEW PLC
| Date | Price | Change |
|---|---|---|
| 24-05-24 | 8.64 | -16.20% |
| 24-05-23 | 10.31 | -27.70% |
| 24-05-22 | 14.26 | +2.15% |
| 24-05-21 | 13.96 | -10.11% |
| 24-05-20 | 15.53 | +4.72% |
Delayed Quote Börse Stuttgart
Last update May 24, 2024 at 06:00 am
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | SMITH & NEPHEW PLC |
| Issuer | Morgan Stanley |
| WKN | MG23XG |
| ISIN | DE000MG23XG8 |
| Date issued | 2024-04-10 |
| Strike | 884.6 p |
| Maturity | Unlimited |
| Parity | 0.13 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 15.53 € |
|---|---|
| Lowest since issue | 8.36 € |
Company Profile
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Sector
-
Consensus: Smith & Nephew Plc
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
12.48
USD
Average target price
16.34
USD
Spread / Average Target
+30.93%
- Stock Market
- Certificates
- Certificat
